Reklama
WIG82 745,58+1,45%
WIG202 436,05+1,72%
EUR / PLN4,31-0,21%
USD / PLN3,99-0,05%
CHF / PLN4,43+0,40%
GBP / PLN5,04+0,02%
EUR / USD1,08-0,16%
DAX18 492,49+0,08%
FT-SE7 959,74+0,35%
CAC 408 205,81+0,01%
DJI39 769,81+0,02%
S&P 5005 250,04+0,03%
ROPA BRENT86,74+1,21%
ROPA WTI82,88+1,42%
ZŁOTO2 220,35+1,30%
SREBRO24,84+1,10%

Masz ciekawy temat? Napisz do nas

twitter
youtube
facebook
instagram
linkedin
Reklama
Reklama

komunikat spółki espi SOPHARMA AD 2021-09-27 10:11

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No96/2021
Date of issue:2021-09-27
Short name of the issuer
SOPHARMA AD
Subject
Treasury shares
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
Sofia, Bulgaria, September 27, 2021 - Sopharma AD (SFA: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that on September 24, 2021 the Company bought 300 000 own shares representing 0.2226% of the share capital of the Company, at a total value of BGN 1 122 000 on the Bulgarian Stock Exchange, the average price per share was 3.740 BGN.
Annexes
FileDescription
Current report_96_buy back_espi.pdfTreasury shares
SOPHARMA AD
(fullname of the issuer)
SOPHARMA ADFarmaceutyczny (far)
(short name of the issuer)(sector according to clasification
of the WSE in Warsow)
1220Sofia
(post code)(city)
IlienskoShosse16
(street)(number)
+359 2 813 42 00+359 2 936 02 86
(phone number)(fax)
(e-mail)(web site)
nd
(NIP)(REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
DateNamePosition / FunctionSignature
2021-09-27Ognian DonevExecutive Director
Czytaj więcej

Artykuły związane z komunikat spółki espi SOPHARMA AD 2021-09-27 10:11